MétaCan
Menu
Back to cohort
Record W4395053138 · doi:10.1055/s-0044-1783020

EUS-guided radiofrequency and ethanol ablation of pancreatic insulinomas: a single-center experience

2024· article· en· W4395053138 on OpenAlexaff
Katarzyna M. Pawlak, Klaudia Kozłowska, S. Jedruszek, Wiktoria Bosy-Gąsior, Anna Wiechowska–Kozłowska

Bibliographic record

VenueEndoscopy · 2024
Typearticle
Languageen
FieldMedicine
TopicNeuroendocrine Tumor Research Advances
Canadian institutionsSt. Michael's Hospital
Fundersnot available
KeywordsMedicineRadiofrequency ablationEndoscopic ultrasoundRadiologyNeuroendocrine tumorsSingle CenterAblationGold standard (test)LesionSurgeryInternal medicine

Abstract

fetched live from OpenAlex

Aims Insulinomas are the most frequent functional pancreatic neuroendocrine tumors (pNETs). While surgical resection remains still the gold standard treatment, endoscopic ultrasound (EUS)-guided ablation using either ethanol (EUS-EA) or radiofrequency (EUS-RFA) is a minimally invasive alternative treatment modality which induces lesion necrosis [ 1 ]. This study presents a single-center experience in treating pancreatic insulinomas<2 cm with EUS-RFA or EUS-EA focusing on safety and efficacy. Methods 275 patients with pNETs based on EUS-guided fine needle biopsy between 2011 and 2023 were retrospectively identified. 30 of these lesions were treated with EUS-RFA and 4 with EUS-EA. Out of these 34, nine were pancreatic insulinomas, which were included in the analysis. Results 9 patients (7 female; mean age 49 years) with pancreatic insulinomas (mean lesion size 11mm; range 6-19mm) were treated with EUS-guided ablation. 7 of 9 patients underwent EUS-RFA and 2 patients EUS-EA due to a difficult location of the lesion. All EUS-RFA procedures (mean total ablation time for lesion 31s; range 17-69s) or EUS-EA (total ethanol volume, 1,4ml and 0,5ml) resulted in an immediate hypoglycemia relief after 1 treatment session. All patients remained asymptomatic (median follow-up 31 months; range, 11-47 months); 8 of 9 patients were followed-up radiologically in CT or/and EUS (median follow-up,15 months; range, 3-36 months ) and 3 patients due to only partial radiological regression were qualified for subsequent ablation sessions (mean session number 1.5; range 1-3); The complete regression of the lesion was observed among 6 patients by imaging modalities (CT or/and EUS). Two patients had minor adverse events (AEs) (local hematoma treated conservatively and upper gastrointestinal bleeding managed endoscopically). No severe AEs occurred. Conclusions Management of pancreatic insulinomas with EUS-RFA and EUS-EA seems to be effective and safe. However, further studies focusing on long-term response and recurrence are needed. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.042
GPT teacher head0.349
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueEndoscopySame topicNeuroendocrine Tumor Research AdvancesFrench-language works237,207